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Introduction
Within the last two to three years most hospital departments
in the British National Health Service (NHS) have been
required to operate within a fixed budget, the preparation
of which can be very complex in departments with employees
of diverse function and expertise. There is also an increasing
demand that the NHS should examine the cost effectiveness
of its service; similar demands are being made in other
countries. Therefore, a department with a specific function
should know the cost of its service, and adjust its budget
with strict regard to the quality of cost efficiency of the
service.
In 1975 the British Department of Health and Social
Security (DHSS) commissioned the preparation of a docu-
ment outlining a scheme for the "total costing" of a patho-
logy laboratory [1]. Costing exercises in clinical chemistry
have since been based on this on this rather complicated
scheme or have been concerned solely with the operation
of a particular instrument. The latter analysis is often super-
ficial, taking into account only the cost of reagents. If
carried out by the manufacturer, the methods of cost analysis
can be obscure and difficult to apply to a particular labora-
tory’s workload or to the comparison of the performance of
similar instruments marketed by different manufacturers.
As capital and running costs of instruments increase it
becomes more important to know the relative costs of carry-
ing out analyses by alternative instrumentation before
purchasing new equipment.
This study describes a new approach to costing the
workload of a hospital laboratory which is less complex than
the total costing scheme of Coopers and Lybrand 1]. The
scheme presented provides a facility for costing a defined
laboratory workload on different instruments, and hence it
is referred to as Relative Costing of Analytical Systems
(RCAS). It takes into account those costs which are likely
to arise in normal circumstances and vary between instru-
ments.
If the workload is made up of a sufficiently broad spectrum
of analyses, then not only the costs of single instruments of
similar capacity, but also those of combinations ofinstruments
of different capacity can be compared. Such combinations
are referred to as systems. It is essential that the workload is
defined before RCAS is applied, and for the costing to be
meaningful the group of analytes under consideration must
constitute a sufficiently large part of the workload. In
theory, costing can be carried out on a smaller workload, but
in practice this is more difficult as data would have to be
corrected to allow for work sharing of instruments, manpower,
and in some cases disposables and reagents. Certain assumpt-
ions have to be made which must be clearly defined at the
outset; they must not invalidate the costing.
The principles of the cost analysis
The analysis is divided into two parts:
(i) costing of individual instruments
(ii) use of this data to cost different analyitical systems
Individual instruments
The costing of instruments and their analyses includes all
items of expenditure which are not part of the fixed laborat-
ory overheads. These are considered under capital cost,
maintenance, manpower, services, control and standardising
materials, disposables and reagents.
Costings are calcuated in three categories:-
(a) Costs associated with the instrument regardless of the
magnitude or complexity of the workload.
(b) Costs related to batches of analyses.
(c) Costs related to individual specimens.
Each item of expenditure is assessed in the most approp-
riate category, for example, capital costs are assessed in
category (a) and reagent costs in category (c). The appropriate
category for other items cannot be specified as it will vary
from one instrument to another. When the analysis is
complete, two sets of data are available for each instrument,
the expenditure related to the instrument ie the sum of the
costs in category(a); and expenditure related to the workload
ie the sum of the costs in categories (b) and (c).
Analytical systems
The cost of an analytical system is the sum of the costs of
the individual instruments included in the system, ie all the
expenditure in category (a) and the expenditure in categories
(b) and (c) which correspond to the appropriate parts of the
workload. The cost per test is not a fixed sum for an analyte
measured by a particular instrument, but is influenced by the
way the instrument is used, that is, if the instrument is used
to measure this particular analyte only, or in combination or
alternation with other analytes.
The overheads excluded from RCAS include personnel
indirectly involved with the instrumentation such as senior
medical, scientific and technical staff, process workers and
secretarial staff, also laboratory overheads such as building
costs, heating, lighting, telephone etc.
Workload
The annual workload of the Clinical Chemistry Department
at Northwick Park Hospital has been chosen as a model for
Table 1. Annual workload model
Analyte
id phosphatase
Albumin
Alkaline phosphatase
Amylase
Aspartate transaminase
Bicarbonate
Bilirubin (total)
Bilirubin (conjugated)
Calcium
Chloride
Cholesterol
Creatine kinase
Creatinine
Gamma glutamyl transferase
Batched
564
42,684
28,346
2,052
28,452
8,232
25,404
276
29,580
1,392
10,848
8,736
11,628
2,604
Glucose
Iron
Iron binding capacity
Lactate dehydrogenase
Phosphate
Potassium
Sodium
Total protein
Triglyceride
Urate
Urea
Multichannel profile
21,732
8,064
8,064
612
28,056
54,984
54.984
42,540
2,472
11,928
53,004
45,252
Nonbatched
156
2,184
240
204
924
36
1,404
3,264
3,264
2,772
Total’
564
42,684
28,346
2,208
28,452
10,416
25,644
480
30,504
1,392
10,848
8,736
11,664
2,604
23,136
8,064
8,064
612
28,056
58,248
58,248
42,540
2,472
11,928
55,776
45,252
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the application of RCAS as it is typical for an average sized
district general hospital. It was determined on the basis of
a detailed study of the analytical data for one month. Work
dealt with during the normal working hours is referred to as
batched analysis while emergency requests made out of
normal working hours are handled separately and referred to
as non-batched analyses. For the purpose of RCAS it is
assumed that non-batched analyses are carried out as separate,
single assays, but samples assayed or Saturday or Sunday
mornings are included among the batched analysis workload.
Table contains a list of the analytes considered suitable
for inclusion in the study. At least 40 requests were received
for each per month and the methods chosen were all capable
of being automated. They were measured by the ’kinetic’ or
’end point’ type of analysis employed in the particular
instruments included in the study. Therefore, thyroxine,
oestrogen, cortisol and 5’-nucleotidase had to be excluded
from the list, but can be subjected to a separate RCAS
analysis. Conjugated bilirubin was included because of the
measurement of total bilirubin although its rate of analysis
was less than 40 per month.
Reagent costing
The number of methods per analyte has been limited to two
for simplicity. Ideally one method should be costed per
analyte but this is only possible if the method is applicable to
all the instruments under consideration. However, different
instruments sometimes require chemically different methods
to measure end-point and the rate of reaction of the same
analyte. By restricting consideration to two methods, those
chosen may not always have been ideal for each instrument
but the costing of the reagents is rendered as comparable as is
possible for all the instruments.
Reagent costing was based on bulk buying of reagents and
kits at prices quoted for the last quarter of 1978, and in
quantities appropriate for the workload. The major suppliers
were BDH Chemicals Ltd, Poole, England; Clin Tech Ltd,
London SE18 5TF and Boehringer Corporation (London)
Ltd, Lewes, England. The proportional quantities of ehch
reagent required in a particular routine method were
calculated and the cost per litre of the final reagent mixture
determined.
It has been assumed that the identity and relative
quantities of the constituents of each final reagent mixture
are invariant with respect to different instruments. This
assumption is not completely valid, but when the cases with
deviations were, investigated, the differences in the individual
costs of the constituents did not significantly change the cost,
of the final reaction mixture. The final reagent cost for each
method considered is given in Table 2. Some analyses require
a blank determination to be carried out and where this
involves different reagents the appropriate cost has been
calculated separately. This approach to costing does not
apply to instruments for which use of the manufacturer’s
reagents and kits is obligatory eg the Du Pont ACA.
Manpower
In RCAS only the manpower used in operating the analytical
instruments is taken into account. This includes the time that
would normally be spent by the operator in day to day
maintenance. It is assumed that operating the type of instru-
ments included in this study does not influence intra
laboratory requirements in expertise and times of employ-
ment of other personnel who do or do not contribute to the
processing of specimens.
Manpower costing has been determined in two ways
according to the type of instrumentation. Annual costing is
used for non-selective multichannel instruments where,
assuming the personnel are employed full time on such
analyses, the manpower, is unaffected by the number of
analytes determined. With the smaller instruments whose
usage and hence manpower utilisation is affected by the
number of analytes measured, hourly costing is applied. The
unit time cost has been calculated on the mean salary of the
Medical Laboratory Scientific Officer (MLSO)for the last
quarter of 1978 plus 20% to cover national insurance and
superannuation etc. Calculation of the hourly rate is based
on a 37 hour,. 5 day week and adjusted for holidays and a
13% deduction for non productive time, ie time not spent
on the actual processes of measurement. The following data
are derived:-
Mean annual MLSO salary
(for last quarter of 1978) 3,970.50
20% (insurance, superannuation) 794.10
Total annual manpower cost/person 4,764.60
Calculation of hourly rate:-
Number of working days (52 x 5) 260 days/annum
Annual leave 20 days/annum
Bank holidays 8 days/annum
StatutOry holidays 2 days/annum
Total days lost 30 days/annum
True number of working days 230 days/annum
Number of working hours 230 x-
1,702 hours/annum
13% non productive time 221 hours/annum
Net number of working hours i,481 hours/annum
4764.6 Hourly rate 1481 3.22/h
In the case of the non-batched analysis, manpower is
covered by a fixed "on-call" payment which is irrespective
of the number of analyses carried out and the type of instru-
ment used; it is therefore excluded from this costing. The
Table 2. Final reagent cost
Analyte Method Cost (pence/1)
ci’phosphatase NitrophenYl phosphate 372.7
Albumin Bromocresol green 38.0
Alkaline phosphatase King and Kind 24.2
Blank 21.1
II Nitrophenyl phosphate 4770.0
Amylase Starch/iodine 8.2
Aspartate transaminase NAD/NADH 4036.0
Blank 4036.0
Bicarbonate Cresol red 2.0
II Carboxylase 2491.0
Blank 40.6
Bilirubin Diazo Michaelsson 59.9
Calcium Cresolphthalein 50.7
Chloride Thiocyanate 11.7
Cholesterol Cholesterol oxidase 6632.0
II Leibermann-Burchard 251.1
Creatine kinase NAD/NADH 23810.0
II Diacetyl/orcinol 6414.6
Creatinine Jaffe 17.8
Blank 0.8
")’-Glutamyl transferase NAD/NADH 6633.0
Blank 6633.0
Glucose Glucose oxidase 108.5
Iron and I.B.C. Ferrozine 59.4
Lactate dehydrogenase NAD/NADH 3800.0
Blank 24.7
Phosphate Stannous chloride 54.9
Sodium and potassium Flame photometry 1.2
II Ion selective electrode 479.0
Protein Biuret 25.2
Blank 20.6
Triglyceride NAD/NADH 11923.0
Blank 9200.0
Urate Uricase 29.0
Blank 135.5
II Phosphotungstate 386.6
Urea Berthelot 103.4
II Diacetyl monoxime 51.0
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manpower costs for Saturday and Sunday mornings are
also covered by "on-call" payments. However, the magnitude
of the workload at these times is such that it was costed as
batched analysis.
Other costs
The costs other than those of reagents and manpower will be
considered here under the appropriate sub-headings.
Capit,al and depreciation
The capital cost of an instrument needs to be included and
should be spread uniformly through its expected working
life. The DHSS recommendation of seven years average life
[1] has been used and depreciation has therefore to be
calculated as one seventh of the capital cost per annum.
To this has to be added the cost of the maintenance contract,
which usually stipulates that the instrument be maintained
under warranty, free of charge for the first year. Therefore,
the total annual depreciation has been calculated as one
seventh of the capital cost plus six sevenths of the annual
maintenance contract. The latter is usually quoted as a
percentage of the capital cost.
Data processing
The data handling capability of instruments varies greatly
and is reflected in their capital cost and manpower require-
ments for data transfer. This has been allowed for by setting
a minimum data processing requirement for each instrument;
this is the ability to interface with a computer capable of
handling the laboratory’s workload. When this requirement
is not met by the instrument an addition is made to the
capital cost to cover suitable interfacing equipment.
Services
The services included are electricity, water and gas. Electricity
and water are calculated as a product of the estimated mean
consumption of the instrument and the local cost per unit,
which gives only an approximate cost as the mean consump-
tion cannot be calculated accurately. Water costiz negligible
and is ignored in almost all cases except multichannel instru-
ments fitted with a laundry system. Where the water
consumption is high the cost of deionising resin is significant
and has been included. Gas requirement is solely that of
propane for flame photometry. Its cost has been based on
purchasing large cylinders appropriate to the size of the
workload.
Commercial sera
Commercial sera used for calibration and control of analyses
vary from one laboratory to another and therefore it is
difficult to make a generalised statement concerning their
cost. The cost calculated here was based on the following
assumptions:-
(i) All calibration is carried out using assayed commercial
sera.
(ii) Unassayed commercial sera are used for all quality
\cOntrol procedures.
(iii) Quality control specimens are included at the frequency
of in 20 for batched analyses and at a frequency of
to in non-batched analyses, unless a more appropriate
frequency is dictated by the instrument.
(iv) The volume of serum used is approximately 10% in
excess of the volume required for the assay.
Costing is based on the mean price of preparations purchased
in quantities appropriate to the workload. The case where a
special serum was required for a particular instrument is
dealt with in the section on instrumentation.
Disposables
These include blood tubes forthe transportation of specimens,
vials for introducing the specimen into the instrument, and
any accessories associated with the analyser which need
Table 3. Instrument associated,costs of Viekers M-
C’aiial "Capital cost ’
125’,000
Manpower
Analysis
data
Services
Commercial
sera
Disposables
Additional
analyses
Maintenance 8% after yr
Capital.depreciation
(125000 8 6
./ + 125000 x 1-’O"O-x if-)
3 full time personnel at 4,764.60/person
Number of specimens/annum 45,252
Number of standards and
controls 70/d
Total number of assays/
annum
(45,252 + 70 x 260) 63,452
.’. Total analysis time/annum
(63452.
300
Run up time
Run down time
Total running time/annum
(211.5 + (2+0.5) x 260)
211.5h/annum
2 h/d
0.5 h/d
861.5 h/annum
Mean electrical consumption 15 KVA/h
Annual cost (consumption x
rate x running time)
1.865 (15x
x 861.5)
Water consumption 601/h
Annual cost (consumption x
rate x running time)
0.0117 (60 x 100 x 861.5)
Annual cost deionisation resin
Annual gas consumption 6 units
Annual cost (6 x 5.50)
Unassaycd serum consumption 90 m/d
Annual cost (unit cost x
consumption)
10.4
]00 x 90x260)
Assayed serum consumption 12.5 ml/d
Annual cost (unit cost x
consumption)
15.0 x 12.5 x 260)
Mean vial cost
Annual vial cost (unit cost x
total assays)
9 (1-’ x 63,452)
Blood tubes cost (unit cost x
number used)
r2.64 40 x 45,252 x ---,) i00 lULl
9p ea
Total
Standards and controls 70/d
Annual analyses (70 x 260) 18,200
Reagent priming time 24 min/d
Annual priming time
24 (0-" x 260) 104 h
Equivalent number of analyses
for purposes of reagent
costing
(104 x 300) 31,200
Total additional analyses
..(18,200 + 31,200) 49,400
Effective annual workload
(workload + additional
analyses)
(45,252 + 49,400) 94,642 VI
oo
An’l’al"
cost
(pounds)
26,428.57
14,293.80
241.00
6.05
624.00
33.0O
2,433.60
487.50
5,710.68
477.86
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replacing at regular intervals, for example pump tubes and
dialyser membranes in continuous flow equipment. Vials are
usually peculiar to the instrument and are therefore costed
individually. In determining the number required, allowances
must be made for the controls and the standards, as well as
for the specimens. Blood tube cost is based on that of plain
glass 10 ml tubes purchased at a bulk rate appropriate to the
workload, the consumption being based on one tube for
every four tests, reflecting a test/request ratio of 4:1 which
the DHSS suggest is the national average [2]. This figure is
not used for the multichannel non-selective instruments
where it is assumed that one tube is used for each profile. No
allowance is made for.special tubes required for certain tests,
for example glucose.
The cost of disposables such as chart paper, request and
result forms are assumed to be invariable within a laboratory
irrespective of the equipment, and therefore have been
omitted.
Instrumentation
Ten different types of instrument have been selected for cost
analysis. As stated previously, reagents have been costed per
unit volume of the final mixture and the reagent cost for an
instrument is based on the volume it consumes. All other
expenses are calculated to assess the total running cost per
annum of the individual instrument. A common costing
pattern is used for all instruments, although its application
varies with the differences in the individual modes of
operation For example an item may have to be classified as
an overhead with one but not necessarily with another.
Table 4. Analyte associated costs of Vickers M-3(10
Consequently a series of formulae are derived for each instru-
ment, two examples of which may be seen in Tables 3 and
5. From these data a total overhead cost is determined and a
total assay cost per analyte per annum is calculated. The
latter, is determined for batched analyses and non-batched
ones where applicable.
In the case of some of the newer instruments data were
not available at the time of compilation for all of the
potential analyses, and these analyses have therefore been
omitted.
The costs of the materials and services are based on infor-
mation which was correct at December 1978 and which are
common to all instruments, they are shown below.
Electricity 1,86 51p/KVA
Water 0.1 17p/1
Gas 5.50/unit
Unassayed commercial sera 10.4p/ml
Assayed commercial sera 15.0p/ml
Blood tubes 2.64p/ea
Blood tube cost per test
on the basis of 4 tests per tube
(where applicable) 0.66p/test
The costs of other materials which are required specifically
for certain instruments are accounted for individually.
Two examples of costing have been given in Tables 3 to
6 which demonstrate two extremes of approach. The Vickers
M300 multichannel analyser is a profiling instrument and
most of its costing is related to the instrument rather than
the workload, whereas the converse is true for the Union
Carbide Centrifichem 400.
Column
"Dei’ivatin
Acid phosphatase
Albumin
Alkaline phosphatase
Blank
Amylase
Aspartate transaminase
Blank
Bicarbonate
Blank
Bilirubin (total)
Bilirubin (conjugated)
Blank
Calcium
Chloride
Cholesterol
Creatine kinase
Creatinine
Blank
Gamma glutamyl transferase
Blank
Glucose
Iron
Iron binding capacity
Lactate dehydrogenase
Blank
Phosphate
Potassium
Sodium
Total Protein
Blank
Triglyceride
Blank
Urate
Blank
Urea
Method
see
Table 2
Sample
volume
(zl)
7
58
58
58
58
3
3
133
133
133
30
3
58
133
Reagent
volume
(ml)
III
3.50
3.50
3.50
2.50
2.50
2.50
2.50
3.50
3.50
3.50
3.50
3.50
2.50
3.50
Reagent
cost/1
(pence)
IX)’
see
Table 2
38.0
24.2
21.1
4036.0
4036.0
2491.0
40.6
59.9
59.9
59.9
50.7
11.7
251.1
17.8
Cost/test
(pence)
v
1--0-0-0- x IV
0.133
0.0847
0.0738
10.090
10.090
6.2275
0.1015
0.2097
0.2097
0.2O97
0.1775
0.0410
0.6278
0.0623
133
58
58
20
25
25
17
15
33
20
20
4
3.50
2.50
2.50
4.00
3.50
3.50
3.50
3.60
3.50
3.40
3.40
3.50
0.8’
66330.0
66330.0
108.5
3800.0
24.7
54.9
1.2
25.2
29.0
135.5
103.4
0.0028
16.5835
16.5825
0.4340
13.3000
0.O865
0.1922
0.0043
0.0882
128
Total
cost
(pounds)
94652
125.89
80.17
69.86
9550.39
9550.39
5894.44
96.05
240.10
240.10
240.10
169.30
38.80
594.22
58.98
2.65
15696.66
15695.66
410.78
12588.72
81.87
181.91
4.06
83.48
0.0986 93.33
0.4607 436.07
0.3619 342.55
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The results of cost analyses carried out on ten different
instruments are shown in Table 7.
Systems costing
Different instruments and/or multiples of the same instru-
ment used in combination to process a defined workload are
referred to as systems. The costing of a system is carried out
by summing the relevant individual instrument costs as in
Table 7. A number of examples of systems costings are
given below.
Workload/cost comparison
The analytes included in the batched workload shown in
Table have been rearranged according to the magnitude of
the workload commencing with the largest. Each is then
costed for each applicable instrument and these costs which
are cumulative, are summed. Figure shows the results of
Table 5. Instrument associated costs of Union Carbide
Centrifichem 400
CaPital Capital cost 37,500
Maintenance 8% after yr
Capital depreciation
7
8 6 (3 500 x 37,500xx -)
""a’npower Full time operator at 3.22/h
Analysis Analysis time variable
data Total number analyses/rotor 29
Priming reagent volume None
Plate changeover time 10 min
Plate sampling time 4 min
Services Electrical consumption 4.8KVA/h
Cost (consumption x rate)
(4.8 x 1.865) 8.952p/h
Annual
Cost
(pounds)
7,928.57
Laundry water + deionising resin 1.3p/1
Methanol 55p/1
Commercial Unassayed serum consumption i00pl/test
sera Cost (unit cost x consumption)
100 (10.4 x i000 1.04p/test
Assayed serum consumption 100 gl]test
Cost (unit cost x consumption)
100 (15.0 x 1000 1.5p/test
Disposables Analyser cups 0.55p/ca
Blood tubes (4 tests/tube)
(2.64_._.) 0.66p/ca 4
Batched
analysis
Total
Reagent usage/rotor (’ unassayed sera + ’2
assayed sera + 25 specimens)
(Reagent volume + 16% reagent volume)
Corrected reagent cost/test
cost/test + 16% cost/test
Total analysis time/rotor (2 unassayed sera
analysis time + 2 assayed sera analysis time
+ blank analysis time + 25 specimen
analysis time + 10 min changeover + 4 min
sampling time)
Corrected analysis time/specimen
14 Analysis time + 20% analysis time +-
min
Total manpower cost (unit cost x total
running time)
(3. 22 x total running time)
Total electrical cost (unit cost x total
running time)
52
00 x total running time)
7,928.57
VI
this costing procedure diagramatically. The point at which
the plot meets the abscissa represents the instrument
associated costs. Thus the expensive multichannel instruments
have poor cost effectiveness at low workloads, although in
this case it is low because not all the channels are in use. With
the smaller instruments a point is reached where no more
work can be handled during the normal working day and so
an additional instrument is required with an additional in-
crease in capital expenditure. Therefore, it is necessary to
determine the analysis time and the total time available
during the normal working day. The latter has been cal-
culated as follows:-
Number of working days (52 x 5) 260 days/annum
Bank holidays 8 days/annum
Statutory holidays 2 days/annum
Total days lost 10 days/annum
Batched
analysis
(cont’d.)
Non
batched
assays
8.952 Manpower/electrical cost (3.22 + 100=
total running time
3.31 x total running
Rotor costs (25 specimens)
(2 assayed sera + 2 unassayed sera + 29 analyser
cups + 25 (1/4) blood tubes)
(1.5 x 2 + 1.04 x 2 + 0.55 x 29 + 0.66 x 25)
Rotor cost/specimen
37.53
25
Laundry cost/rotor
Water + resin (100 ml)
Methanol (40 ml)
37.53p/
rotor
1.50121/specimen
0.13p/rotor
Z2p/rotor
Water + resin + methanol
Cost/specimen
2.33 0.0932p/specimen 25
2.33p/rotor
XI
XII
XXII
XXII
Reagent usage/specimen (2 assayed sera +
unassayed serum + specimen)
Reagent volume + 300% reagent volume)
Corrected reagent cost/test
cost/test x 4 XV
Total analysis time/specimen
(2 assayed sera analysis time + unassayed
sera analysis time + blank analysis time +
specimen analysis time + 10 min changeover)
(sampling time is excluded as rotor is only
partially filled)
Corrected analysis time/specimen
analysis time x 5 + 10 min
Manpower cost not applicable
Total electrical cost (unit cost x total
running time)
8.952
100: x total running time XX
Rotor cost/specimen
(2 assayed sera + unassayed serum + 4
analyser cups + (1/4) blood tube)
(1.5 x 2 + 1.04 + 0.55 x 4 + 0.66)
6.9p/specimen
Laundry cost]rotor
For non batched analysis the cost/rotor
and cost]specimen are the same, i.e.
0.0932p/specimen
XIX
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True number of working days 250 days/annum
Number of working hours (250 x 3,.7) 1,850 h/annum
13% (non productive time) 240.5 h/annum
Maximum analysis time 1,609.5 h/annum
In Figure the points of discontinuity of some graphs
indicate the stage where an additional instrument is required.
The points of inflection occur where the analyte associated
costs are higher than the average for that instrument.
Multiehannel instruments
The total cost of running each of the four multichannel
instruments at full capacity is compared. Except for the
Hycel-M none of these is. capable of analysing the complete
workload model and therefore a suitable selection of analytes
is made as shown in parenthesis below. For the SMAll sys-
tem, costing is based on a 16. channel instrument including a
flame unit. Costs are as follows :-
Vickers M-300 78,405.90 (Albumin, alkaline phospha-
tase, aspartate transaminase,
bicarbonate, total bilirubin,
calcium, chloride, creatinine,
glucose, phosphate, potas-
sium, sodium, total protein,
urate, urea)
Key to
Figure 1.
Hycel M
Technicon SMAll (6 channels)
Technicon SMAll (16 channels)
Technicon AAII
Coulter Kern-O-Mat
Abbot VP
i 600
I’
500
400-
 oo-
2oo-
100
0
0 90 100
Cost/annum (thousand pounds)
Figure 1. Annual test relationship.
Centrifichem 400 Vickers M-300
DuPont ACA Technicon SMAC
Table 6 Analyte associated costs of Union Carbide Centrifiehem 400
sample Regen’t Reagent Cost/
volume volume cost/1 test
Column
Derivation
Acid phosphatase
Albumin
Alkaline phosphatase
Blank
Amylase
Aspartate transaminase
Blank
Bicarbonate
Blank
Bilirubin (total)
Bilirubin (conjugated)
Blank
Calcium
Chloride
Cholesterol
Creatine kinase
Creatinine
Blank
9’glutamyl transferase
Blank
Glucose
Iron
Iron binding capacity
Lactate dehydrogenase
Blank
Phosphate,
Potassium
Sodium
Total protein
Blank
Triglyceride
Blank
Urate
Blank
Urea
Method
see
Table 2
(ul) (ml)
II III
(pence) (pence)
IV’ ’V"
see III
Table 2 1000
x IV
3 0.407 38.0 0.0155
5 0.305 4770.0 1.4549
40 0.305 4036.0 1.2310
10
5
10
10
5
25 0.305 59.9 0.0183
40 0.305 59.9 0.0183
0.305 59.9 0.0183
5 0.405 50.7 0.02053
5 0.375 6632.0 2.487
15 0.385 2380.0 9.1669
40 0.405 17.8 0.0072
25 0.305 6633.0 2.0231
5 0.305 108.5 0.0331
100 0.250 59.4 0.0149
100 0.250 59.4 0.0149
10 0.300 3800.0 1.1400
Corrected Reagnt Total
reagent Annual annual Analyses running
cost/test workload cost time
(pence) (pounds) (min/spec) (h/annum)
VI VH"’ viii I’X X
v + i6% V see vI x vii (ix+20%IX
Table T0-0" 14) VII
0.0180 42684 7.68 0.133 511.9
1.6877 28236 476.54 0.033 282.2
1.4280 28452 406.29 0.033 284.3
0.0212.’ 25404 5.39 0.133 304.7
0.0212 276 0.06 0.033 2.8
0.0212 25404 5.39 0.033 253.9
0.0238 29580 9.04 0.033 295.6
2.8849 10848 312.96 0.500 209.7
10.6336 8736 928.95 0.033 116.2
0.0084 11628 0.98 0.033 116.2
2.3468 2604 61.11 0.033 26.0
0.0384 21732 8.35 0.200 289.8
0.0’]73 8064 1.40 0.333 129.0
0.0173 8064 1.40 0.333 129.0
1.3224 612 8.09 0.033 6.1
0.405 25.2 0.0102 0..0118
0.375 1192.0 0.4470 0.5183
0.300 29.0 0.0087 0.0101
0.300 135.5 0.0405 0.0470
0.375 103.4 0.0388 0.450
Columns VI to XIV refer only to batched analysis
42540 5.02 0.033 425.1
2472 12.82 0.0333 39.5
11928 1.21 0.167 151.2
11928 5.61 0.167 151.2
53004 23.85 0.008 503.2
Columns XV to XIX refer only to non-batched analysis
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Technicon SMAC 62,212.60 Albumin, alkaline phospha-
tase, aspartate transaminase,
bicarbonate, total and conju-
gated bilirubin, calcium, chlo-
ride, cholesterol, creatine,
kinase, creatinine, glucose,
lactate dehydrogenase, phos-
phate, potassium, sodium,
total protein, triglyceride,
urate, urea)
Hycel-M 53,700.14
Technicon SMAll 49,178.57 (same as Vickers M-300)
These figures are not directly comparable for two reasons.
The number of analytes determined is different; 15 with the
M-300, 20 with the SMAC, 25 with the Hycel-M and 15 with
the SMAll. The Hycel-M assays the complete workload model
whereas the other three non-selective instruments cover only
the profile workload defined by their capacity. The difference,
therefore, between the performance of Hycel-M and the
others is the total workload minus the respective profile
workloads which is approximately 10,000 assays for sodium,
potassium, bicarbonate and urea, plus the non-batched work-
load.
Systems using smaller instruments
Examples of systems capable of carrying out the batched and
non-batched workload are shown below using different com-
binations of Kem-O-Mat, Abbott VP and Centrifichem. The
cost of an AAII flame unit is included as none of these
instruments is capable of sodium and potassium analysis.
AAII Flame Unit + 5 Kem-O-Mats
Flame Unit 5,154.18
Kem-O-Mat 57,320.40
Total/annum 62,474.58
The analytes excluded are acid phosphatase, amylase, bicarb-
onate, 7-glutamyl transferase, iron and IBC.
AA11 Flame Unit + 3 VPs
Flam.e Unit 5,154.18
VP Instruments 43,878.70
Total/annum 49,032.88
Acid phosphatase is the only analyte exluded.
AAII Flame Unit + 3 Centrifichems
Flame Unit 5,154.18
Centrifichems 46,93 2.03
Total/annum 52,086.21
The analytes excluded are acid phosphatase, amylase,
bicarbonate, chloride and phosphate.
AAII Flame Unit + Kem-O-Mat + 2 VPs
Flame Unit 5,154.18
Kem-O-Mat 9,825.22(Creatine, urea)
VPs 33.408.70(rest of the analyses)
Total/annum 48.388.10
Acid phosphatase is the only analyte excluded.
Table 6.continued
Electrical Specimen Laundry Total
coanumWer
cost/ cost/ cost/
annum annum annum
(pounds) (pounds) (pounds) (pounds)
XI XII XIII XIV
3.31 x X 1.5012
-’-jVII 032VII VIII+XI+XII+xIII
Corrected Annual Amlysis Total Electrical Specimen Laundry Total
reagent Annual cost time running cost/ cost/ cost/ cost/
cost/test workload reagent (mini time annum annum annum annum
(pence) (pounds) spec) (h/annum) (pounds) (pounds) (pounds) (pounds)
XV XVI xvII xvIII XIx ’xx xxi xxII xxIIi
4v see xv as IX (sxvIII+ 8.952 6.9 2.33 xvIi/XX+
Table 1-XVI 10)_
xXIX 100 1-XVI 1-’XVI XXKXI
1696.39 640.77 39.78
934.08 423.88 26.31
941.03 427.12 26.55
1008.58 381.36 23.71
9.27 4.14 0.23
840.41 381.36 23.71
978.44 444.05 27.57
694.11 162.85 10.08
657.37 131.14 8.11
384.62 174.56 10.88
86.06 39.09 2.44
959.24 326.24 20.24
427.00 121.06 7.48
427.00 121.06 7.48
20.26 9.19 0.55
1407.08 638.61 39.70
130.75 37.11 2.29
500.47 179.06 11.11
500.47 179.06 11.11
1665.59 795.70 49.47
2382.62
’1860.81
1800.99
1419.04
13.70
1250.87
1457.10
1180.00
1725.57
571.04
188.70
1314.07
556.94
556.94
38.09
2090.41
182.97
691.85
692.25
2534.61
0.0732 240
0.0732 204
0.0732 240
0.0821 924
0.0288
0.1324
0.1552
36
1404
2773
O.
0.
0.18
0.76
0.01
1.86
18 0.133 42.7 3.82 16.56 5.92 26.48
15 0.033 34.6 3.10 14.08 4.75 22,08
0.033 40.7 3.64 16.56 5.92 26.30
0.033 156.5 14.01 63.76 21.53 100.06
0.033 6.1 0.55 2.48 0.84 3.88
0.200 237.9 21.30 96.88 32.71 152.75
4.30 0.008 496.6 42.04 191.27 64.59 302.20
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AAII Flame Unit + 2 Kern-O-Mats + 2 Centrifichems
Flame Unit 5,154.18
Kem-O-Mats 18,876.84(Calcium, chloride,
creatinine, phos-
phate, urea)
Centrifichems 34,034.57(rest ofthe analyses)
Total/annum 58,065.59
The analytes excluded are acid phosphatase, amylase and
bicarbonate.
Conclusions
A method is proposed for assessing the cost of the annual
workload and the capital depreciation of an instrument or
instruments. The protocol has been standardised as much as
possible so that it is easily applicable to all instruments
currently used or to be used in clinical chemistry laboratories,
individually or comparatively. This is one of the main
advantages of RCAS over cost analyses carried out elsewhere
as part of instrument evaluations on some instruments
considered in the present study [3-5].
In the application of RCAS certain assumptions are made,
particularly with respect to overheads which have been
considered to be independent of the operation of the instru-
ments. If at any time for any reason, one of these assumptions
is considered invalid, suitable adjustments can be made to
the cost analysis. A capital depreciation allowance is made
for data processing equipment as an accessory to some
instruments in order to level their performance with that of
more advanced models which can be interfaced with a
computer. It was not intended here, however, to include an
analysis of computer costing. This, and the overheads referred
to above are assumed to be independent of instrumentation
and could be the subjects of separate RCAS programmes. A
Table 7. Instrument cost analysis (pounds/annum)
combination of all three would give a total costing similar
to that of Coopers and Lybrand ].
Ten types of instrument have been costed covering the
range which is, or soon will be, available in the UK to the
clinical chemist for the analysis of end point and/or rate of
reaction. Combinations of these instruments have been
costed for the execution of a defined workload with the
general conclusion that the more recently introduced instru-
mentation is more economic, and that if the correct combin-
ation is used it makes little difference whether the system is
based on a large multichannel analyser or a series of smaller
discrete instruments. The costing of the newer instruments
is based more on the theory than the practice of operation
and therefore it is possible that the data used give a falsely
low costing.
One of the most important aspects of instrumentation
not considered by RCAS or other costing procedures is the
quality of analysis. This cannot be evaluated mathematically
but it can be assessed comparatively for different instruments
and therefore provides a basis for justification of the cost of
a particular chemical method or instrument.
The equipment and systems covered in this paper represent
only a small part of the total number available but the study
was laborious and time consuming. It is suggested that
RCAS would operate most effectively through a computer
program. It is also recommended that a costing file containing
all the information concerning the cost of capital, reagents,
disposable items, service and manpower should be kept and
updated periodically to allow for price increases. A separate
file could contain instrumentation details with the new
information entered as it becomes available. A relative cost
analysis could then be carried out at any time for a given
workload using any specified combination of instruments.
The compilation of such a program would make it easier
Instrument
Instrument associated
costs
Type of workload
Vickers
M-300
50,736.60
Technicon
SMAC
Batched
Technicon
AA II
see below (c)
Non
batched
82.55
2,202.20
6,171.95
53.49
43.71
14,688.45
316.02
37.67
4,069.55
588.59
1,408.35
234.19
1.408.35
1,593.72
275.66
747.05
3,193.13
744.33
1.267.25
590.83
590.83
543.88
157.10
1,525.63
2,727.78
2,218.37
2,207.17
2,049.05
50,955.O5
Profile
Hyiei
M
45,671.46
Technicon
SMA II
see below
(b) Non
Total (a) Profile batched
Analyte Analyte associated costs (pounds)
Acid phosphatase 9.43 553.89
Albumin 125.89 7.06 13.96 50.14
Alkaline phosphatase 80.17 707.39 2,202.89 7,087.53
Blank 69.86
Amylase 0.28
Aspartate transaminase 9, 550.39 256.52 999.96 3,849.37
Blank 9,550.39
Bicarbonate 5,894.44 0.44 449.58 4.21 8.30
Blank 96.05
Bilirubin (total) 240.10 9.63 15.10 58.58 115.47
Bilirubin (conjugated) 240.10 9.63 0.86 58.58 115.47
Blank 240.10 9.63 15.10 58.58 115.47
Calcium 169.30 14.26 13,45. 43.08 84.92
Chloride 38.80 1.30 0.25 9.93
Cholesterol 594.22 93.34 1,242.01 133.69
Creatine kinase 2,242.23 1,955.85 10,148.80
Creatine 58.98 1.65 2.32 4.37 8.62
Blank 2.65 0.10
Gamma glutamyl transferase 15,695.66 203.18
Blank 15,695.66
Glucose 410.78 33.64 41.33 118.10 232.81
Iron 4.54 45.78
Iron binding capacity 4.54
Lactate dehydrogenase 12,588.72 735.53 52.84 6,655.89
Blank 81.87 44.59
Phosphate 181.91 1.59 13.41 47.53
Potassium 4.06 89.03 1.12 1.27 2.51
Sodium 71.03
Total protein 83.48 4.68 9.24
Blank 3.85
Triglyceride 3,880.82 660.17
Blank 2,994.51
Urate 93.33 77.81 4.34
Blank 436.07 20.30
Urea 342.55 11.98 92.53
858.03
207.95
27.29
23.20
27.29
100.15
3.43
188.15
307.51
74.26 2,680.07 295.62
LKB
8600
(d)
2,150.00
Batched
111.01
4,14o.7o
3,910.48
2,012.84
4,625.94
836.16
324.01
1,036.93
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to deal with the problem of cost changes due to inflation.
Meanwhile it can be said that from the beginning of the last
quarter of 1978 to the end of the first quarter of 1980,
manpower costs have been increased by 25.2% based on the
change in the mean salary of the MLSO and other costs by
24.5% based on the change in the retail price index.
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Key to Table 7.
(a) The HyceI-M is designed to be maintained in a standby mode
and therefore batched and non-batched analyses may be costed
together.
(b) The instrument associated costs for SMAll are 16,767.79
excluding pump tubes (64.20 per channel) and capital depreciation
and maintenance. These costs are dependent upon the number of
channels and whether a flame unit is included. Figures are quoted
below for 6 to 16 channels including flame unit.
6 channels 9,990.00
7 channels 10,836.00
8 channels 11,470.00
9 channels 12,633.90
10 channels 14,324.00
11 channels 15,487.00
12 channels 16,544.00
13 channels 17,390.00
14 channels 18,553.00
15 channels 19,187.00
16 channels 19,610.00
The instrument associated costs cover profile and non-batched work
as it is assumed that an instrument used for non-batched analysis
would also be used for profiling. If the non-batched analysis is to be
included however, there is an additional 1,546.00 to cover services,
commercial sera and disposables costs.
(c) Instrument associated costs have been calculated for flame units
and dual channel systems only, these are 2,118.89 and 1,637.35
per channel respectively.
(d) The cost of an LKB 2082-018 Kinetic Data Processor has been
included under the capital.
(e) At the time this data was collated no information was available
on the manufacturers maintenance contract. This has been assumed to
be 5% of capital cost. Also, an allowance has been made in the capital
cost to cover a micro-processor and interfacing equipment which were
not currently available.
(f) This costing is based on the "fee per test" method and therefore
there is no instrument associated cost.
Coulter
KEM-O-MAT
Abbott
VP
Centrifichem
400
Du Pont
ACA
(e) 6,649.43 7,928.57 None (f)
2,730.00
Non- Non Non Non
Batched Batched Batched Batched Batched Batched Batched Batched
897.92
4.509.18
3,638.32
21.12
17.93
21.12
81.31
3.13
127.49
3,526.65
2,319.67
2,144.10
127.08
2,1’16.90
551.40
1,381.51
14.90
1,608.55
80.78
894.55
1,186.19
631.20
204.81
1,268.82
16.27
336.03
25.25
21.45
97.14
3.75
149.11
2,685.02
29.18
2,685.02
3,127.38
146.80
1,158.67
1,988.43
1,226.54
2,382.62
1,860.81
1,800.99
1,419.04
13.70
1,250.87
1,457.10
1,180.00
1,725.57
571.04
188.70
1,314.07
26.48
22.08
26.30
100.06
3.88
152.75 2,316.16
27,308.25
18,247.29
1,886.15
18,409.77
5,663.61
16,323.05
658.79
19,079.17
1,366.55
7,307.13
5,996.32
7,813.24
2,149.22
14,146.85
75.45
2,966.13
4,488.53
440.11
1,258.99
1,266.19
5,618.37 247.18
469.70
469.70
42.82
1,141.08
2,4.73.25
225.40
743.38
2,891.60 294.01
556.94
556.94
38.09
2,090.41
182.97
691.85
696.25
2,534.61 302.20
5,602.93
5,602.93
892.38
18,120.03
27,230.29
2,046.66
7,989.21
33,791.85
359.40
2,939.63
554.27
471.12
1,487.80
83.71
2,040.67
3,617.93
Volume 2 No. 3 July 1980 133